CREDIT SUISSE AG/ - NURIX THERAPEUTICS INC ownership

NURIX THERAPEUTICS INC's ticker is NRIX and the CUSIP is 67080M103. A total of 103 filers reported holding NURIX THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of NURIX THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$411,298
-29.7%
52,328
-10.7%
0.00%
-100.0%
Q2 2023$585,185
+140.5%
58,577
+113.8%
0.00%
Q1 2023$243,312
-19.1%
27,400
+0.0%
0.00%
Q4 2022$300,753
-20.0%
27,391
-5.1%
0.00%
Q3 2022$376,000
+90.9%
28,850
+84.7%
0.00%
Q2 2022$197,000
-3.0%
15,619
+7.9%
0.00%
Q1 2022$203,000
-48.7%
14,474
+5.7%
0.00%
Q4 2021$396,000
-3.6%
13,695
-0.0%
0.00%
Q3 2021$411,000
+50.5%
13,698
+32.8%
0.00%
Q2 2021$273,000
-10.8%
10,313
+5.0%
0.00%
Q1 2021$306,000
-47.6%
9,826
-44.7%
0.00%
Q4 2020$584,00017,7820.00%
Other shareholders
NURIX THERAPEUTICS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 1,822,883$18,210,6011.88%
DAFNA Capital Management LLC 556,695$5,561,3831.52%
Deep Track Capital, LP 2,997,830$29,948,3221.39%
Redmile Group, LLC 2,857,309$28,544,5171.10%
WestHill Financial Advisors, Inc. 283,333$2,830,4970.80%
Boxer Capital, LLC 1,224,892$12,2370.57%
AtonRa Partners 30,142$301,1190.47%
Affinity Asset Advisors, LLC 100,000$999,0000.35%
HARVARD MANAGEMENT CO INC 314,762$3,1440.31%
WASATCH ADVISORS LP 3,869,775$38,659,0520.23%
View complete list of NURIX THERAPEUTICS INC shareholders